Please log in to see the full text of this API!
Telmisartan
-
Synonyms:
BIBR 277, BIBR 277SE
-
ATC:
C09CA07
-
Use:
Lorem
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:514.63 g/mol
-
CAS-RN:144701-48-4
-
InChI Key:RMMXLENWKUUMAY-UHFFFAOYSA-N
-
InChI:InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
114772-40-6 |
C18H19BrO2 |
tert-butyl 4'-(bromomethyl)biphenyl-2-carboxylate |
[1,1'-Biphenyl]-2-carboxylic acid, 4'-(bromomethyl)-, 1,1-dimethylethyl ester |
141-75-3 |
C4H7ClO |
butyryl chloride |
Butanoyl chloride |
144702-26-1 |
C37H38N4O2 |
4'-[[1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-[1,1'-biphenyl]-2-carboxylic acid 1,1-dimethylethyl ester |
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[[1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-, 1,1-dimethylethyl ester |
18595-14-7 |
C9H11NO2 |
methyl 4-amino-3-methylbenzoate |
Benzoic acid, 4-amino-3-methyl-, methyl ester |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem ipsum |
Lorem
|
comb. |
F |
Lorem |
Lorem
|
|
Lorem ipsum |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem ipsum |
Lorem
|
|
GB |
Lorem |
Lorem
|
|
I |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
J |
Lorem |
Lorem
Lorem
|
|
USA |
Lorem ipsum |
Lorem
|
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,seddiam
References
-
- Ries, U. et al.: J. Med. Chem. (JMCMAR) 36, 4040-4051 (1993).
- US 9 999 999 (Thomae; 7.1.1997; D-prior. 6.2.1991, 25.5.1991, 16.11.1991, 22.1.1992, 11.4.1992, 17.6.1992, 22.7.1992, 27.7.1992, 4.8.1992).
- EP 999 999 (Thomae; 9.9.1992; appl. 31.1.1992; D-prior. 6.2.1991).
- DE 9 999 999 (Thomae; 21.9.1995; appl. 14.3.1994; D-prior. 14.3.1994).
-
use for the treatment of a condition associated with hypoxia or unpaired metabolic function:
- WO 9 999 999 (Eurogene Ltd.; appl. 19.10.1998; GB-prior. 17.10.1997).
-
use to treat symptomatic heart failure:
- WO 9 999 999 (Merck & Co.; appl. 7.1.1998; USA-prior. 10.1.1997).
-
method to treat cardiofibrosis with a combination of an ATII-antagonist and spironolactone:
- WO 9 999 999 (G. D. Searle; appl. 5.6.1996; USA-prior. 7.6.1995).